VBI Vaccines Inc. (TSE:VBV – Get Free Report)’s stock price fell 5.1% during mid-day trading on Monday . The stock traded as low as C$4.82 and last traded at C$4.82. 1,300 shares were traded during trading, a decline of 64% from the average session volume of 3,637 shares. The stock had previously closed at C$5.08.
VBI Vaccines Stock Performance
The stock has a market cap of C$308.86 million and a PE ratio of -4.97. The company has a debt-to-equity ratio of 14.29, a current ratio of 2.64 and a quick ratio of 2.54.
VBI Vaccines Company Profile
VBI Vaccines Inc, a biopharmaceutical company, develops and sells vaccines to address unmet needs in infectious disease and immuno-oncology in Israel and internationally. The company offers Sci-B-Vac, a third-generation hepatitis B vaccine for adults, children, and newborns; and eVLP, a vaccine platform for the design of enveloped virus-like particle vaccines that closely mimic the target virus.
Recommended Stories
- Five stocks we like better than VBI Vaccines
- How Technical Indicators Can Help You Find Oversold StocksĀ
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- Where to Find Earnings Call Transcripts
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for VBI Vaccines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VBI Vaccines and related companies with MarketBeat.com's FREE daily email newsletter.